Related Experiment Video
Updated: Jul 8, 2026
08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
Recent advances in natriuretic peptide research
Geoffrey E Woodard1, Juan A Rosado
1The National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1876, USA. GeoffreyW@niaid.nih.gov
Journal of Cellular and Molecular Medicine
|January 22, 2008
Summary
Natriuretic peptides, like brain natriuretic peptide (BNP) and NT-proBNP, are key biomarkers for heart failure diagnosis and prognosis. Their role in renal function and therapeutic use, including nesiritide, is also reviewed.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Background:
- Natriuretic peptides are vital hormones regulating cardiovascular and renal homeostasis.
- Brain natriuretic peptide (BNP) and NT-proBNP are established biomarkers in heart failure.
- Elevated levels of BNP and NT-proBNP indicate heart failure and predict outcomes.
Purpose of the Study:
- To review the clinical utility of BNP and NT-proBNP in heart failure management.
- To discuss the renoprotective effects of natriuretic peptides.
- To examine the therapeutic applications and controversies surrounding nesiritide.
Main Methods:
- Literature review of studies on natriuretic peptides in cardiovascular and renal diseases.
- Analysis of diagnostic, prognostic, and therapeutic roles of BNP and NT-proBNP.
- Evaluation of clinical trial data for nesiritide.
Main Results:
- BNP and NT-proBNP are effective in diagnosing, screening, and monitoring heart failure.
- Natriuretic peptides demonstrate renoprotective properties in renal failure.
- Nesiritide shows potential for symptomatic improvement but carries a potential increased short-term mortality risk.
Conclusions:
- BNP and NT-proBNP are indispensable tools in heart failure management.
- Further research is needed to clarify the long-term safety and efficacy of nesiritide.
- Natriuretic peptides hold promise for broader therapeutic applications in cardiovascular and renal conditions.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...